Table 5 Risk factor analysis for aneurysmal growth after endovascular aortic repair (EVAR)
Decreased AAA, n = 22 | No change or increased AAA, n = 12 | p | |
|---|---|---|---|
Age, years | 75.5 ± 9.2 | 76.1 ± 7.4 | 0.85 |
Male gender, n (%) | 15 (68) | 10 (83) | 0.44 |
HTN, n (%) | 15 (68) | 10 (83) | 0.44 |
DM, n (%) | 5 (23) | 0 (0) | 0.14 |
CAOD, n (%) | 4 (18) | 2 (17) | 1.00 |
CVA, n (%) | 4 (18) | 3 (25) | 0.68 |
CRF, n (%) | 1 (5) | 1 (8) | 1.00 |
Antiplatelet agent, n (%) | 11 (50) | 8 (67) | 0.35 |
Statin, n (%) | 9 (41) | 7 (58) | 0.33 |
Diameter of AAA, mm | 56.7 ± 8.3 | 58.1 ± 11.5 | 0.70 |
Mural thrombus, ml | 69.3 ± 42.6 | 93.0 ± 93.5 | 0.42 |
Fresh thrombus, ml | 45.1 ± 40.3 | 38.4 ± 45.3 | 0.66 |
Gas formation, n (%) | 10 (45) | 7 (58) | 0.47 |
Fever, n (%) | 9 (41) | 2 (17) | 0.25 |
WBC, ×103/μl | 13.4 ± 4.5 | 14.3 ± 5.0 | 0.58 |
PLT, ×103/μl | 218.1 ± 70.0 | 243.1 ± 55.0 | 0.29 |
CRP, mg/dL | 10.7 ± 6.0 | 11.5 ± 7.2 | 0.74 |
ESR, mm/h | 80.0 ± 21.0 | 55.5 ± 37.9 | 0.07 |